American Trust’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,680
| Closed | -$353K | – | 308 |
|
|
2023
Q4 | $353K | Sell |
2,680
-370
| -12% | -$48.8K | 0.03% | 183 |
|
|
2023
Q3 | $343K | Sell |
3,050
-750
| -20% | -$84.4K | 0.03% | 196 |
|
|
2023
Q2 | $358K | Sell |
3,800
-120
| -3% | -$11.3K | 0.02% | 264 |
|
|
2023
Q1 | $397K | Sell |
3,920
-2,610
| -40% | -$264K | 0.03% | 249 |
|
|
2022
Q4 | $780K | Buy |
+6,530
| New | +$780K | 0.07% | 152 |
|